People
Dr Pradip Bhatnagar is Head of Daiichi Sankyo Life Science Research Centre, India (RCI). His responsibilities include leading a team of more than 160 scientists responsible for drug discovery research in the areas of anti-infectives and inflammation, coordinating research and development with Daiichi Sankyo, Japan. Prior to this, Dr Bhatnagar headed New Drug Discovery Research (NDDR) at Ranbaxy. He joined Ranbaxy in 2005, as the Senior Vice President of Drug Discovery Research.
Dr Bhatnagar gained a variety of research, development and managerial experience in various positions at GlaxoSmithKline and its several affiliates/predecessors, including SmithKline Beecham and SmithKline & French. His responsibilities included managing international alliances, drug discovery and development research, as well as managing and leading a large team of researchers.
Dr Bhatnagar earned a master's and doctorate degree in Medicinal Chemistry from the University of Wisconsin, and a master's degree in Organic Chemistry from Meerut University, India. He also holds an MBA from Temple University Pennsylvania. Dr Bhatnagar has published over 70 papers in peer-reviewed journals and holds 32 patents.
Dr M.K. Bhan is M.B.B.S, M.D. Pediatrics, D. Sc. (Honorary), Fellow, Indian National Science Academy (FNA), Fellow, Academy of Sciences (F.ASc) and Fellow, Academy of Medical Sciences (F.A.M.S.). Dr Bhan holds numerous awards in recognition of his work, including the highest award for science in India, the Shanti Swarup Bhatnagar Award 1990.
Dr Bhan is involved with policy formulation in his various roles as Chairman/Board Member of various committees to do with child health research, vaccines and nutrition, including Chairman of the WHO Task Force on child health research.
Dr Bhan is a Member of the Jury for almost all major national science awards in India.
Professor Sanjay Govind Dhande is the Director of the Indian Institute of Technology Kanpur. IIT Kanpur is an internationally acclaimed institution known for its excellence in engineering education and research. Professor Dhande is also a member of the Scientific Advisory Council to the Prime Minister of India (PM-SAC).
As Director of IIT Kanpur, Professor Dhande has made innovative steps in the field of technical education. Under his direction new initiatives have been undertaken in Biological Sciences and Bio Engineering, Environment and Earth system Sciences under MP LAD Scheme giving a best model for public-public partnership in a sustainable way.
Professor Christine Ennew is Pro Vice Chancellor at the University of Nottingham where she has responsibility for the University's innovative Internationalisation strategy and also for and the Faculty of Science. She was formerly Dean of the Faculty of Social Sciences, Law and Education and is also Professor of Marketing in the Business School.
Rebecca Fairbairn is a research policy specialist. A social scientist by training (Universities of Edinburgh and Bristol), she has led on UK government initiatives covering a range of academic disciplines- from space science to biodesign, international relations to solar energy- and is currently focused on raising the profile of the UK research base in India.
Rebecca began her career with the UK Research Councils (the biggest public sector funder of research in the UK) where she was responsible for numerous research schemes and joint initiatives across government. She also led, for all seven UK Research Councils, on joint engagement with UK Parliamentary Select Committees.
In 2008 Rebecca came to India on a Research Councils UK project to develop the strategy and set up the operations for the RCUK Office in India. During that time she was invited to head the UK government's Science and Innovation Network (S&IN) in Bangalore. S&IN is a global network of science attaches that works to influence governments to use robust scientific knowledge in policy development, and to raise the profile of the UK as a world leading knowledge economy. Rebecca is also Deputy Head of Mission for the British Deputy High Commission in Bangalore.
Dr Alicia Greated is Director of Research Councils UK (RCUK) India. RCUK is the strategic partnership of the UK's seven Research Councils who are the leading public funders of basic research in the UK and have a combined budget of around £3 billion annually. Alicia moved to India in 2008 to lead on the establishment of 'RCUK India', in New Delhi.
Alicia has worked for the Research Councils since 2001. She was Head of the Engineering Programme at the Engineering and Physical Sciences Research Council (EPSRC) where she led on the strategic direction of engineering research activities and managed a budget of £100 million annually. She also worked as Associate Director of Research at the Arts and Humanities Research Council (AHRC) where she managed AHRC's research division, including the international team.
Alicia has a PhD in molecular microbiology and a degree in biochemistry.
She has also worked for short periods of time teaching and doing research in China, Africa and Brazil.
Mr John Griffiths
Dr Susan Huxtable, Director of Technology Transfer, The University of Nottingham.
The Technology Transfer Office manages and exploits intellectual property arising from a broad range of research activity. As a result the University has more than 30 trading spin-out companies and a large portfolio of licensed technology.
Dr Richard Masterman was appointed as Director of Research Innovation Services at the University of Nottingham in 2005 and has responsibility for leadership, management and support of all the University's research and knowledge transfer activities which include an active and diverse research and knowledge transfer portfolio of more than 2000 projects with a current value of more than £500 million. This responsibility covers a wide range of external and internal research and business development, commercialisation and postgraduate policy activities and engaging with all types of research and commercial sponsors, regionally, nationally and internationally. He has worked at the University in roles supporting research and graduate strategy and policy development and implementation since 1992 with some broader experience of supporting University governance. Prior to that, he completed a NERC funded PhD at Nottingham.
Dr Mittal is an alumni of the National Dairy Research Institute and the Indian Institute of Management (IIM) Ahmedabad. He has been instrumental in giving a new vibrancy to promoting the innovation and entrepreneurial acumen among a wide section of Indian entrepreneurs ranging from simple rural industries to high end technological enterprises.
Shri. Mittal's two decades long association with the Government has coincided with the beginning of India's economic liberalization initiatives. He has made the innovation and entrepreneurship programme of Department of Science & Technology a much sought after programme by the individual entrepreneurs as well as by the industry and technological circles - not only in India but among the industrially advanced countries of the world. He has been responsible for establishing networks with international development institutions like the World Bank and EU and for bringing the global incubation knowledge to the Indian business incubators and has represented India at various international forums on innovation, entrepreneurship and incubation.
Professor S Ramaswamy is Dean of the Institute for Stem Cell Biology and Regenerative Medicine, and CEO of the Center for Cellular and Molecular Platforms. His current duties include helping with the extramural and translational activities of InSTEM as well as setting up and managing C-CAMP into being a sustainable not-for profit technology management and development company. He also has a research program relating structure and function of biological molecules.
Professor Ramaswamy obtained his PhD in molecular biophysics in 1992 at the Indian Institute of Science in Bangalore and conducted postdoctoral research in X-ray crystallography from 1992 to 1994 at the Swedish University of Agricultural Sciences in Uppsala. From 2000 to 2009, he was an active, productive and highly collaborative faculty member at The University of Iowa Department of Biochemistry, who contributed greatly to the growth of structural biology at the Carver College of Medicine. In June 2009, he accepted a position as Senior Professor and Dean of InSTEM, the Institute for Stem Cell Science and Regenerative Medicine in Bangalore, India.
Tobby Simon is the founder, President and CEO of Synergia Bio Sciences, a life sciences company, focused on manufacturing and the design and implementation of strategies to translate early stage research to market. He is also the President of Synergia Foundation, a think tank that works closely with industry, polity and academia to establish leading edge practices through applied research in areas of business continuity planning, risk and security analysis. A graduate of the Harvard Business School (HBS) and a Research Affiliate at the Massachusetts Institute of Technology (MIT), Tobby has over two decades of senior management experience in the pharmaceutical industry covering broad disciplines including commercial, supply chain management, manufacturing, regulatory, marketing and international business. As part of his commitment to humanitarian causes, Tobby worked pro bono over a decade for Nobel Prize winner, Medicines Sans Frontier (MSF) and the World Health Organization (WHO) to build end to end supply chain solutions for procurement of anti-retroviral generics from India.
He is a member of the International Council of the Belfer Centre of Science and International Affairs at the John F. Kennedy School of Government, Harvard University, a member of the Advisory Board of Centre for New American Security (CNAS), a Washington based think tank and a member of the International Institute for Strategic Studies (IISS). He is also the Regional Director of Harvard Business School's Health Care Industry Alumni Association. Tobby is currently pursuing his PhD on International Security at the National Institute of Advanced Studies (NIAS, Indian Institute of Science) and is a Special Professor at Nottingham University Business School.
Dr Nigel Whittle has 25 years experience in the biotechnology industry, in a range of senior scientific, commercial and managerial roles. After graduating from Oxford University and Imperial college, Nigel worked at Genentech (USA), then Celltech and Cantab Pharmaceuticals (UK), where he was responsible for overall company project development. After completing an MBA at Cambridge University, he went on to drive technology commercialisation from Kings College London, helping to float one start-up company on AIM.
Most recently he has been working with UKTI to assist major overseas pharmaceutical companies invest in the UK's R&D capabilities through identification of appropriate scientific and business opportunities. He works with a portfolio of companies in the USA, Japan and India, and has been instrumental in brokering deals and procuring investments worth several million pounds. He is also on the advisory boards of a number of commercial and governmental organisations.
